(Q38153753)

29 August 2017

title

Simeprevir for the treatment of chronic hepatitis C. (English)

1 reference

29 August 2017

1 reference

1 reference

David M You

1

1 reference

29 August 2017

Paul J Pockros

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

19 October 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

18

1 reference

29 August 2017

page(s)

2581-2589

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Hepatitis C therapy with HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Telaprevir for previously treated chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Boceprevir for previously treated chronic HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.850074

10.1517/14656566.2013.850074

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference